Navigation Links
Ezra Van Gelder Joins Microchip Biotechnologies as Executive Vice President R&D
Date:12/4/2008

DUBLIN, Calif., Dec. 4 /PRNewswire/ -- Microchip Biotechnologies, a private company developing the Apollo next-generation fluidics platform for Life Sciences, announced today that Ezra Van Gelder has joined its team as Executive Vice President of R&D.

Ezra Van Gelder brings Microchip Biotechnologies (MBI) extensive leadership experience in research and development from the life science, medical device and semiconductor equipment industries. Prior to joining MBI, Ezra Van Gelder headed instrument and reagent development for DNA and RNA sample preparation at Arcxis Biosciences. At Molecular Dynamics, Amersham and GE Healthcare, where he was VP of Development for the West Coast, he led development for DNA sequencing and cell analysis. In the semiconductor industry Ezra Van Gelder directed the development of automated optical wafer inspection equipment at KLA Instruments and KLA-Tencor.

"The addition of Ezra Van Gelder, as Executive VP of R&D, further strengthens the world class team at MBI. Ezra brings considerable expertise in developing innovative next generation life science solutions focused on end users and implementing product development processes and ISO 13485," said Dr. Stevan Jovanovich, President and CEO of Microchip Biotechnologies. "Ezra's R&D leadership and experience will accelerate the full integration of sample preparation and analysis on MBI's Apollo platform."

"I have spent much of my career working on separate reagent and analytical instrumentation systems, so I am now relishing the prospect of working with a platform that can genuinely integrate macro and microfluidics to provide much needed, complete sample-to-answer solutions," said Ezra Van Gelder. "The Apollo platform, along with the exceptional group at MBI, will bring new capabilities to life sciences, diagnostics and compact field portable devices for life science applications."

Ezra Van Gelder holds a B.Sc. in Mechanical Engineering from Tel Aviv University, Israel and a M.Sc. in Mechanical Engineering from Santa Clara University, California, USA.

About Microchip Biotechnologies

Microchip Biotechnologies, Inc., also known as MBI, is a privately-held company that is located in Dublin, California. The company is developing the Apollo next-generation fluidics platform for life sciences, applied sciences, and diagnostics markets. The Apollo platform integrates advanced microfluidic sample preparation, and analytical capabilities, to produce sample-to-answer performance for DNA sequencing, biodefense, DNA-based forensics and human identity (HID), and molecular diagnostics applications. The platform incorporates MBI's proprietary BeadStorm(TM) bead-based sample preparation devices and 'Microscale On-Chip Valve' (MOVe(TM)) valves, pumps, and routers on NanoPulse(TM) microchips. More details about the MBI, its technologies and products can be found at: www.microchipbiotech.com.


'/>"/>
SOURCE Microchip Biotechnologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Richard Greco Joins Mediware Board
2. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
3. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
4. Dr. Mahesh Ramachandran Joins Marianjoy Medical Group
5. Nick Childs Joins Grey New York as Director of Content Development
6. Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
7. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
8. NASN Joins Partnership to Fight Chronic Disease
9. AstraZeneca Joins Local Walking Movement
10. Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
11. Fund Manager Joins Board of GSI Securitization Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
Breaking Medicine Technology: